Figure 2. Cumulative incidence of NFI for risk groups defined by the adjusted prediction rule, using WHO leprosy classification and presence of anti-PGL-I antibodies as predictive variables.

NFI = nerve function impairment, PGL-I = phenolic glycolipid I.